Navigation Links
Cepheid to Present at Cowen and Company's 28th Annual Healthcare Conference
Date:3/10/2008

SUNNYVALE, Calif., March 10 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) will present at Cowen and Company's 28th Annual Healthcare Conference on March 18 at 10:15 a.m. ET at The Boston Marriott Copley Place in Boston. John L. Bishop, Chief Executive Officer, will provide a corporate overview.

The webcast, along with accompanying presentation slides, may be accessed on Cepheid's Web site at http://www.cepheid.com under Investors: Events: Webcasts and Presentations. A replay of the webcast presentation will be available for 90 days.

About Cepheid

Cepheid (Nasdaq: CPHD), based in Sunnyvale, California, is a molecular diagnostics company that develops, manufactures, and markets fully-integrated systems for genetic analysis in the clinical, industrial and biothreat markets. The company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The company's easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation, DNA amplification and detection, which enable the analysis of complex biological samples in its proprietary test cartridges. Through its strong molecular biology capabilities, the company is focusing on those applications where rapid molecular testing is particularly important, such as identifying infectious disease and cancer in the clinical market; food, agricultural, and environmental testing in the industrial market; and identifying bio-terrorism agents in the biothreat market. See http://www.cepheid.com for more information.

(Logo:

SOURCE Cepheid
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Cepheid Reports Fourth Quarter and Full Year 2007 Results
2. Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market
3. Cepheid Appoints Senior VP, Chief Financial Officer to Management Team
4. Cepheid Schedules Teleconference and Webcast for 2007 Fourth Quarter and Full Year Results
5. Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System
6. Cepheid to Present at the Piper Jaffray 19th Annual Healthcare Conference
7. Cepheid to Present at William Blair Small-Cap Growth Stock Conference
8. Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB
9. Cepheid to Present at Thomas Weisel Partners Healthcare Conference
10. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
11. AutoGenomics to Present at Cowen Health Care Conference on March 17, 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...The New York investment bank KTA Capital,s client ... AU$6.7 mil convertible note private placement wit...ment was arranged by KTA Capital as Neuren,s exclu... New York (PRWEB) November 23, 2009 -- T...l, LLC ("KTA Capital") has announced tha...
(Date:11/24/2009)...,Ontario,Nov.24/PRNewswire-FirstCall/--DowAgroScie...landSeeds,adivisionofThompsonsLimitedofBlenheim,On...AgroSciences,currentseedsbusinessasthecompanyantic...dDowAgroSciencesHerbicideTolerantTraitTechnologyin...rfuture. ,, "Thisacquisitionbringstogethertwost...
(Date:11/24/2009)...Newswire-FirstCall/--Sigma-AldrichCorporation(Nasd...onTuesday,December1stat1:45PMGMTinLondon,7:45AMUS/...tovertheInternetavailableat http://inve s tor.s...t"icontoaccessthisfile. ,, AboutSigma-Aldrich...logycompany.Itschemicalandbiochemicalproductsandki...
(Date:11/24/2009)...November24/PRNewswire-FirstCall/--deCODE,genetics,...fits,"firstday"motionsbytheU.S.BankruptcyCourtfort...lastweekfiledavoluntarypetitionfor,reliefunderChap...ptcyCourt. , TheordersissuedbytheBankruptcyCo...uringtheChapter11proceedings.Inparticular,the,comp...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3
...als, Inc. (Nasdaq: ISIS ) announced today that it...(Ibis), has been awarded four new,government contr...tection,and identification of microbial threat age...ntracts are from the Department of Homeland Securi...d total up to approximately,$3.3 million and a fou...
...SE: EHP) announced today that it has completed the... for potential biodefense drugs, and are,about to ...over the coming,year. The National Institutes of ...logical and Nuclear Threats (MCART) programme lead...ion sickness following a nuclear terrorist,attack....
...:,BIOD) today announced that it will amend its Qua...d ended June 30, 2007 to correct the manner in whi...nsation expense arising from,stock options granted...any,s initial public offering. The amendment will ...olely non-cash in nature. On May 10, 2007, the Co...
Other Biology Technology:Isis Announces $4.2 Million in Government Contracts Awarded to Its Ibis Subsidiary for Biodefense Applications Development 2Isis Announces $4.2 Million in Government Contracts Awarded to Its Ibis Subsidiary for Biodefense Applications Development 3Isis Announces $4.2 Million in Government Contracts Awarded to Its Ibis Subsidiary for Biodefense Applications Development 4EpiStem Successfully Complete First Year of Mucositis Tests for NIH Biodefence Programme 2EpiStem Successfully Complete First Year of Mucositis Tests for NIH Biodefence Programme 3Biodel to Amend June 30, 2007 10-Q to Correct Non-Cash Share-Based Compensation Expense 2Biodel to Amend June 30, 2007 10-Q to Correct Non-Cash Share-Based Compensation Expense 3
(Date:11/23/2009)...ence that the "synergistic" effect of early-life e...and indoor endotoxin causes more harm to developin... Environmental health scientists at the Universit...n that children exposed to both high levels of tra... early life are six times more likely to experienc...
(Date:11/23/2009)...plied mathematicians dissected the morphology of t...istic long leaf with a saddle-like arc midsection ...mple cause of the lily,s fan-like shapeelastic rel... growthwas revealed by using an equally simple tec...a postdoctoral student at Harvard,s School of Engi...
(Date:11/23/2009)...Society says that western lowland gorillas living ...he "mother lode" of more than 125,000 gorillas dis...ned by growing humans activity in the region. , ...ts adjacent to the southwest border of Lac Tl Comm...high densities of the great apes still exist in th...
Breaking Biology News(10 mins):Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2The cause behind the characteristic shape of a long leaf revealed 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Watchful waiting is a viable option for prostate cancer patients with low risk tumors 55761 1Watchful waiting is a viable option for prostate cancer patients with low risk tumors 55761 2Watchful waiting is a viable option for prostate cancer patients with low risk tumors 55761 3Abbott to Present at Morgan Stanley Global Healthcare Unplugged Conference 55759 1Family Circle Magazine Features AmLactin 28R 29 in Article on Managing Dry Skin Associated With Keratosis Pilaris 55757 1Family Circle Magazine Features AmLactin 28R 29 in Article on Managing Dry Skin Associated With Keratosis Pilaris 55757 2
...or bioengineered crops, sequencing the genome coul.... Once the sequence is complete, the baton is pass...ions. A draft sequence of the soybean genome is no...able soon. Taking the next step in a new study, Un... researchers have demonstrated the applicability o...
...entory" of sea and land animals around a group of ... biodiversity and has more species than the Galapa...monitor how they will respond to future environmen... of Biogeography , the team from British Antarctic...ey combed the land, sea and shores of the South Or...
...(Sweden) Permission has been granted to start the...or a remedy for ALS. ALS is an incurable, paralyzi...ns in every 100,000. The disease commonly affects ...lives − without warning. Researchers from VI...ibilities for the use of VEGF in the treatment of ...
Other Biology News:Tool helps identify gene function in soybeans 2First trial in patients with a potential treatment of the incurable ALS muscle disease 2First trial in patients with a potential treatment of the incurable ALS muscle disease 3
...DA-GT12 Genetic Analyzer is a revolutionary multi...ultiple applications in one instrument platform. I...data analysis in one step, thus significantly impr... of medium to high-throughput laboratories . Bene...
...otofor purification system, 100-120 V, is used for...se isoelectric focusing (IEF). The system includes...ng chambers, chassis, harvesting apparatus, coolin...lytes (pH 3-10), 60 ml syringe, colored protein sa...
...mmEdge Pen, a hydrophobic barrier pen for immunohi...ed for use with frozen or paraffin-embedded tissue... provides a heat-stable, water-repellent barrier t...e sections, prevents mixing of reagents when diffe...
NBT/BCIP Chromogen System (SIGNET) from Covance Research Products, Inc
Biology Products: